Drug Class
ALK and ROS1 tyrosine kinase inhibitor
Type
ingredient
Active Ingredient
lorlatinib
📋Overview
Lorlatinib is a targeted therapy drug classified as a tyrosine kinase inhibitor. It is primarily associated with the treatment of certain types of non-small cell lung cancer that have specific genetic mutations, such as alterations in the ALK or ROS1 genes. Lorlatinib works by blocking the activity of these mutated proteins, which can help slow the growth and spread of cancer cells. It is used in cases where cancer has progressed or is resistant to other similar medications.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Lorlatinib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.